NCT02192177

Brief Summary

Intrahepatic cholestasis of pregnancy is a disease specific to pregnancy period; especially late second and third trimester. We aimed to investigate the role of apoptosis in etiopathogenesis of obstetric cholestasis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 12, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 16, 2014

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

July 16, 2014

Status Verified

July 1, 2014

Enrollment Period

11 months

First QC Date

July 12, 2014

Last Update Submit

July 14, 2014

Conditions

Keywords

Apoptosisintrahepatic cholestasisobstetric outcomes

Outcome Measures

Primary Outcomes (1)

  • M30 value as Unit per Liter.

    Four months.

Secondary Outcomes (1)

  • Percentage of delivery with cesarean section.

    Four months.

Study Arms (2)

Group 1

Pregnant subjects diagnosed with obstetric cholestasis who didn't have any foreknown systemic disease.

Group 2

entirely healthy pregnant subjects, the control group.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients who admitted our clinic without foreknown systemic diseases or multiple pregnancy.

You may qualify if:

  • Late second or third trimester of pregnancy.

You may not qualify if:

  • Foreknown systemic diseases, multiple pregnancy, smoking cigarettes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zekai Tahir Burak Maternity Teaching Hospital

Ankara, Ankara, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Del Ben M, Polimeni L, Baratta F, Bartimoccia S, Carnevale R, Loffredo L, Pignatelli P, Violi F, Angelico F. Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver. Int J Hepatol. 2014;2014:784985. doi: 10.1155/2014/784985. Epub 2014 Jan 29.

    PMID: 24678423BACKGROUND
  • Du Q, Zhang Y, Pan Y, Duan T. Lithocholic acid-induced placental tumor necrosis factor-alpha upregulation and syncytiotrophoblast cell apoptosis in intrahepatic cholestasis of pregnancy. Hepatol Res. 2014 May;44(5):532-41. doi: 10.1111/hepr.12150. Epub 2013 May 31.

    PMID: 23627780BACKGROUND

Biospecimen

Retention: NONE RETAINED

Maternal venous and umbilical cord blood.

MeSH Terms

Conditions

Cholestasis, Intrahepatic

Condition Hierarchy (Ancestors)

CholestasisBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesLiver Diseases

Study Officials

  • Ali O Ersoy

    Medical doctor

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

July 12, 2014

First Posted

July 16, 2014

Study Start

September 1, 2013

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

July 16, 2014

Record last verified: 2014-07

Locations